Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization.
Beech C, Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim J, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D.
Beech C, et al. Among authors: davis r.
Appl Immunohistochem Mol Morphol. 2025 Jan 27. doi: 10.1097/PAI.0000000000001247. Online ahead of print.
Appl Immunohistochem Mol Morphol. 2025.
PMID: 39866038